Real-world effectiveness of fostamatinib in patients with immune thrombocytopenia: a single-center retrospective study

International Journal of Hematology · Published 2026-08-04 · DOI 10.1007/s12185-026-04243-w

Free full text

Authors (6)

Katsumichi Fujimaki, Takaaki Takeda, Kota Kawabata, Ayako Bouno, Yuki Nakajima, Hideaki Nakajima

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Fujimaki, K., Takeda, T., Kawabata, K., et al. (2026). Real-world effectiveness of fostamatinib in patients with immune thrombocytopenia: a single-center retrospective study. International Journal of Hematology. https://doi.org/10.1007/s12185-026-04243-w

Related articles

• Recent advances in the pathophysiology and treatment of GVHD · International Journal of Hematology · 2026 · Same journal
• Immunological links between aplastic anemia and paroxysmal nocturnal hemoglobinuria · International Journal of Hematology · 2026 · Same journal
• Current status and challenges of TCR-T cell therapy for AML/MDS · International Journal of Hematology · 2026 · Same journal
• T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel · International Journal of Hematology · 2026 · Same journal
• NPM1-rearranged AML: clinical features, molecular pathogenesis, and therapeutic perspectives · International Journal of Hematology · 2026 · Same journal
• Postmarketing surveillance study of asciminib in patients with resistant/intolerant chronic myeloid leukemia in Japan · International Journal of Hematology · 2026 · Same journal
• Genomic insights transform diagnosis, prognosis, and therapy in BCR::ABL1-negative myeloproliferative neoplasms · International Journal of Hematology · 2026 · Same journal
• Defibrotide for late-onset sinusoidal obstruction syndrome following umbilical cord blood transplantation: a single-center retrospective study · International Journal of Hematology · 2026 · Same journal
• Zanubrutinib for MYD88-negative Waldenström’s macroglobulinemia with massive splenomegaly · International Journal of Hematology · 2026 · Same journal
• Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan · International Journal of Hematology · 2026 · Same journal